Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

Lemin Zheng(Capital Medical University), Stanley L. Hazen(Cleveland State University)
Journal of Clinical Investigation
August 16, 2004
Cited by 647


Related Papers